What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
Quaglino
Pietro
P
Osella-Abate
Simona
S
Savoia
Paola
P
Bernengo
Maria Grazia
MG
Cappello
Nazario
N
Cavallo
Franco
F
D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood* / Q000235:genetics; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D058965:MART-1 Antigen; D008545:Melanoma / Q000097:blood / Q000235:genetics* / Q000473:pathology; D008562:Membrane Glycoproteins / Q000097:blood; D014442:Monophenol Monooxygenase / Q000097:blood; D009363:Neoplasm Proteins / Q000097:blood; D009367:Neoplasm Staging; D011379:Prognosis; D012333:RNA, Messenger / Q000097:blood*; D012334:RNA, Neoplasm / Q000097:blood*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012878:Skin Neoplasms / Q000097:blood / Q000235:genetics* / Q000473:pathology; D016019:Survival Analysis; D058951:gp100 Melanoma Antigen
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; C072013:MAGEA3 protein, human; D058965:MART-1 Antigen; C548667:MLANA protein, human; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; C548637:PMEL protein, human; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D058951:gp100 Melanoma Antigen; D014442:Monophenol Monooxygenase